drug · small molecule
patient view →(carbidopa + levodopa) CR
Phase 1updated 2mo agoby Hong Kong WD Pharmaceutical Co Ltd🔗 ChEMBL
Phase 1community read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 4 approved and 24 investigational indications.
targets
Aromatic-L-amino-acid decarboxylase
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that